Frequency of fibromyalgia syndrome and anxiety post-corona virus disease-2019 (COVID-19) in patients attending the rheumatology clinic

Senara, Soha; Salah, Hisham; Wahed, Wafaa Abdel; Yehia, Ahmed

doi:10.1016/j.ejr.2022.11.007

Cited by 5 publications

(2 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 ). Eighty of the studies were designed in cohort [ 87 – 166 ], 71 cross-sectional [ 16 – 86 ], 7 case control [ 167 – 173 ], 4 survey study [ 174 , 176 – 178 ], 1 randomized clinical trial [ 15 ] and 2 secondary analysis [ 175 , 179 ]. Included studies were published between 2019–2023.…”

Section: Resultsmentioning

confidence: 99%

The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis

Seighali,

Abdollahi,

Shafiee

et al. 2024

BMC Psychiatry

View full text Add to dashboard Cite

Background Post COVID-19 syndrome, also known as "Long COVID," is a complex and multifaceted condition that affects individuals who have recovered from SARS-CoV-2 infection. This systematic review and meta-analysis aim to comprehensively assess the global prevalence of depression, anxiety, and sleep disorder in individuals coping with Post COVID-19 syndrome. Methods A rigorous search of electronic databases was conducted to identify original studies until 24 January 2023. The inclusion criteria comprised studies employing previously validated assessment tools for depression, anxiety, and sleep disorders, reporting prevalence rates, and encompassing patients of all age groups and geographical regions for subgroup analysis Random effects model was utilized for the meta-analysis. Meta-regression analysis was done. Results The pooled prevalence of depression and anxiety among patients coping with Post COVID-19 syndrome was estimated to be 23% (95% CI: 20%—26%; I2 = 99.9%) based on data from 143 studies with 7,782,124 participants and 132 studies with 9,320,687 participants, respectively. The pooled prevalence of sleep disorder among these patients, derived from 27 studies with 15,362 participants, was estimated to be 45% (95% CI: 37%—53%; I2 = 98.7%). Subgroup analyses based on geographical regions and assessment scales revealed significant variations in prevalence rates. Meta-regression analysis showed significant correlations between the prevalence and total sample size of studies, the age of participants, and the percentage of male participants. Publication bias was assessed using Doi plot visualization and the Peters test, revealing a potential source of publication bias for depression (p = 0.0085) and sleep disorder (p = 0.02). However, no evidence of publication bias was found for anxiety (p = 0.11). Conclusion This systematic review and meta-analysis demonstrate a considerable burden of mental health issues, including depression, anxiety, and sleep disorders, among individuals recovering from COVID-19. The findings emphasize the need for comprehensive mental health support and tailored interventions for patients experiencing persistent symptoms after COVID-19 recovery.

show abstract

Section: Resultsmentioning

confidence: 99%

The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis

Seighali,

Abdollahi,

Shafiee

et al. 2024

BMC Psychiatry

View full text Add to dashboard Cite

show abstract

“…FM syndrome is a complex condition with many distress and symptoms [13]. It has a detrimental impact on quality of life but does not yet have any identifiable symptoms, imaging, or laboratory findings.…”

Section: Discussionmentioning

confidence: 99%

Value of Mesotherapy in Treatment of Fibromyalgia

Senara,

Tantawy,

Abel Wahed

et al. 2023

Egyptian Journal of Medical Research

View full text Add to dashboard Cite

Aim: To evaluate the potential benefit of mesotherapy in the treatment of tender points in fibromyalgia (FM) patients in terms of improving functional ability and quality of life. Methods: The American College of Rheumatology's 2016 criteria were met by sixty Primary FM patients who were enrolled in this study. They were divided randomly into two groups in accordance with the program that was given. Group I: 30 patients received: ketoprofen 150 mg /day for two weeks orally and then on demand + methylprednisolone (MP) 40 mg/weeks for the first 4 weeks intramuscularly, then 40mg/2weeks for another month, `+ esomeprazole 20 mg/day for the study period (two months).Group II: 30 patients received mesotherapy injections in the most painful tender points: 2% lidocaine (1 mL) + ketoprofen 100 mg (2 mL) + MP 40 mg (1 mL) every week for the first month, then every 2 weeks the second month. Patients" pain severity, quality of life and depression will be assessed using visual analogue scale (VAS), fibromyalgia impact questionnaire

show abstract

Coronavirus disease 2019 (COVID-19) infection in patients with rheumatic diseases: Clinical characteristics and relation to anti-rheumatic therapy

Aboud,

Yousef,

El Bably

et al. 2023

The Egyptian Rheumatologist

View full text Add to dashboard Cite

Frequency of fibromyalgia syndrome and anxiety post-corona virus disease-2019 (COVID-19) in patients attending the rheumatology clinic

Cited by 5 publications

References 34 publications

The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis

The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis

Value of Mesotherapy in Treatment of Fibromyalgia

Coronavirus disease 2019 (COVID-19) infection in patients with rheumatic diseases: Clinical characteristics and relation to anti-rheumatic therapy

Contact Info

Product

Resources

About